$44.38
0.63% yesterday
Nasdaq, Sep 18, 10:00 pm CET
ISIN
US45332Y1091
Symbol
NARI

Inari Medical Inc Stock price

$44.38
-5.46 10.96% 1M
+2.75 6.61% 6M
-20.54 31.64% YTD
-21.67 32.81% 1Y
-31.63 41.61% 3Y
+1.87 4.40% 5Y
+1.87 4.40% 10Y
Nasdaq, Closing price Wed, Sep 18 2024
+0.28 0.63%
ISIN
US45332Y1091
Symbol
NARI
Sector

Key metrics

Market capitalization $2.59b
Enterprise Value $2.51b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 126.22
EV/Sales (TTM) EV/Sales 4.58
P/S ratio (TTM) P/S ratio 4.72
P/B ratio (TTM) P/B ratio 6.09
Revenue growth (TTM) Revenue growth 24.67%
Revenue (TTM) Revenue $547.47m
EBIT (operating result TTM) EBIT $-23.26m
Free Cash Flow (TTM) Free Cash Flow $19.88m
Cash position $109.74m
EPS (TTM) EPS $-0.98
P/E forward negative
P/S forward 4.28
EV/Sales forward 4.15
Short interest 8.71%
Show more

Is Inari Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Inari Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Inari Medical Inc forecast:

11x Buy
69%
5x Hold
31%

Analyst Opinions

16 Analysts have issued a Inari Medical Inc forecast:

Buy
69%
Hold
31%

Financial data from Inari Medical Inc

Jun '24
+/-
%
Net Profit -31 -31
1,600% 1,600%
-21%
Depreciation and Amortization 4.74 4.74
121% 121%
3%
Stock Compensation 13 13
26% 26%
9%
Operating Cash Flow 12 12
18% 18%
8%
Investments 4.58 4.58
272% 272%
3%
Dividend Paid - -
-
-
Free Cash Flow 7.75 7.75
9% 9%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Inari Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inari Medical Inc Stock News

Neutral
GlobeNewsWire
20 days ago
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that data from the PEERLESS trial will be presented by Dr. Wissam Jaber, Professor of Medicine at Emory University School of Medicine, during the Late-Breaki...
Neutral
GlobeNewsWire
28 days ago
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences:
Positive
InvestorPlace
about 2 months ago
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of MedTech stocks.
More Inari Medical Inc News

Company Profile

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Head office United States
CEO Andrew Hykes
Employees 1,300
Founded 2011
Website www.inarimedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today